Kate Therapeutics Funding & Investors

Kate Therapeutics is a patient-focused biotechnology company developing AAV-based gene therapies to treat genetically defined muscle and heart diseases.

katetherapeutics.com

Total Amount Raised: $51,000,000

Kate Therapeutics Funding Rounds

Series A
$51,000,000
Jun 7, 2023
Series A Investors
Versant Ventures
Westlake Village BioPartners
Osage Industries
UF Innovate Ventures

Funding info provided by Diffbot.